- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/867 - Retroviral vectors
Patent holdings for IPC class C12N 15/867
Total number of patents in this class: 1471
10-year publication summary
|
114
|
99
|
103
|
117
|
106
|
128
|
148
|
128
|
108
|
94
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University Health Network | 1066 |
27 |
| The Regents of the University of California | 20815 |
26 |
| The Children's Hospital of Philadelphia | 864 |
16 |
| Shanghai Unicar-therapy Bio-medicine Technology Co., Ltd | 24 |
15 |
| Beijing Meikang Geno-immune Biotechnology Co., Ltd. | 26 |
15 |
| Ospedale San Raffaele S.r.l. | 315 |
14 |
| The Trustees of the University of Pennsylvania | 4423 |
13 |
| Institut Pasteur | 778 |
13 |
| Oxford Biomedica (UK) Limited | 53 |
13 |
| Theravectys | 62 |
13 |
| Shenzhen Genocury Biotech Co., Ltd. | 30 |
12 |
| Shenzhen Institutes of Advanced Technology | 1530 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3010 |
10 |
| Nanjing Bioheng Biotech Co., Ltd | 50 |
10 |
| Kelonia Therapeutics, Inc. | 50 |
10 |
| Genetix Biotherapeutics Inc. | 113 |
10 |
| Centre National de La Recherche Scientifique | 11059 |
9 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3275 |
9 |
| Shanghai NK Cell Tech Co., Ltd. | 20 |
9 |
| American Gene Technologies International Inc. | 87 |
8 |
| Other owners | 1208 |